There is one new side effect, however, that was not seen in earlier Phase 2 trials
These include gastrointestinal effects like nausea, vomiting and abdominal pain, as well as fainting, headache, migraine, dehydration, acute pancreatitis and gallstones
Indeed, pioglitazone-induced heart failure (HF) and the withdrawal of rosiglitazone because of cardiovascular concerns eventually led to a change in the policy of regulatory authorities.9,10 The US Food and Drug Administration and the European Medicines Agency now require all new antidiabetic drugs to undergo large cardiovascular outcome trials (CVOTs) to confirm cardiovascular safety and benefits
HEP synthesis in liver is controlled by four pathways: (i) iron store-related regulation, (ii) erythropoietic activity-driven regulation, (iii) inflammation-related regulation, and (iv) mandatory signaling pathway
This combination contributes to improved glucose control and weight loss
Kerr EH, Hameed O, Lewis JS, Jr., Bartolucci AA, Wang D, Said-Al-Naief N